| Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity O Gunduz-Cinar, KP MacPherson, R Cinar, J Gamble-George, K Sugden, ... Molecular psychiatry 18 (7), 813-823, 2013 | 338 | 2013 |
| Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation RJ Bluett, JC Gamble-George, DJ Hermanson, ND Hartley, LJ Marnett, ... Translational psychiatry 4 (7), e408-e408, 2014 | 159 | 2014 |
| Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation DJ Hermanson, ND Hartley, J Gamble-George, N Brown, BC Shonesy, ... Nature neuroscience 16 (9), 1291-1298, 2013 | 127 | 2013 |
| Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation DJ Hermanson, JC Gamble-George, LJ Marnett, S Patel Trends in pharmacological sciences 35 (7), 358-367, 2014 | 122 | 2014 |
| α-Synuclein stimulates a dopamine transporter-dependent chloride current and modulates the activity of the transporter J Swant, JS Goodwin, A North, AA Ali, J Gamble-George, S Chirwa, ... Journal of Biological Chemistry 286 (51), 43933-43943, 2011 | 98 | 2011 |
| Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapses TS Ramikie, R Nyilas, RJ Bluett, JC Gamble-George, ND Hartley, ... Neuron 81 (5), 1111-1125, 2014 | 87 | 2014 |
| Chronic methamphetamine exposure produces a delayed, long‐lasting memory deficit A North, J Swant, MF Salvatore, J Gamble‐george, P Prins, B Butler, ... Synapse 67 (5), 245-257, 2013 | 83 | 2013 |
| Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice V Echeverria, S Burgess, J Gamble-George, R Zeitlin, X Lin, C Cao, ... Neuroscience 162 (4), 1220-1231, 2009 | 71 | 2009 |
| HIV, Tat and dopamine transmission PJ Gaskill, DR Miller, J Gamble-George, H Yano, H Khoshbouei Neurobiology of disease 105, 51-73, 2017 | 64 | 2017 |
| Cyclooxygenase-2 inhibition reduces stress-induced affective pathology JC Gamble-George, R Baldi, L Halladay, A Kocharian, N Hartley, ... Elife 5, e14137, 2016 | 50 | 2016 |
| Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice JC Gamble-George, JR Conger, ND Hartley, P Gupta, JJ Sumislawski, ... Psychopharmacology 228, 401-409, 2013 | 45 | 2013 |
| HIV-related stigma research as a priority at the National Institutes of Health GL Greenwood, A Wilson, GP Bansal, C Barnhart, E Barr, R Berzon, ... AIDS and Behavior 26 (Suppl 1), 5-26, 2022 | 44 | 2022 |
| In Parkinson's patient-derived dopamine neurons, the triplication of α-synuclein locus induces distinctive firing pattern by impeding D2 receptor autoinhibition M Lin, PM Mackie, F Shaerzadeh, J Gamble-George, DR Miller, ... Acta Neuropathol Commun 9 (1), 107, 2021 | 23 | 2021 |
| Maternal morbidity and mortality: are we getting to the “heart” of the matter? J Varagic, P Desvigne-Nickens, J Gamble-George, L Hollier, ... Journal of Women's Health 30 (2), 178-186, 2021 | 21 | 2021 |
| Chronic Methamphetamine Increases Alpha-Synuclein Protein Levels in the Striatum and Hippocampus but not in the Cortex of Juvenile Mice B Butler, J Gamble-George, P Prins, A North, JT Clarke, H Khoshbouei J Addict Prev 2 (2), 6, 2014 | 20 | 2014 |
| Raf inhibitors as therapeutic agents against neurodegenerative diseases S Burgess, V Echeverria CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2010 | 20 | 2010 |
| Raf inhibition protects cortical cells against β-amyloid toxicity V Echeverria, S Burgess, J Gamble-George, GW Arendash, BA Citron Neuroscience letters 444 (1), 92-96, 2008 | 20 | 2008 |
| HIV‐1 T at regulation of dopamine transmission and microglial reactivity is brain region specific DR Miller, F Shaerzadeh, L Phan, N Sharif, J Gamble‐George, ... Glia 66 (9), 1915-1928, 2018 | 16 | 2018 |
| ImPlementation REsearCh to DEvelop interventions for people living with HIV (the PRECluDE consortium): combatting chronic disease comorbidities in HIV populations through … JC Gamble-George, CT Longenecker, AR Webel, DH Au, AF Brown, ... Progress in cardiovascular diseases 63 (2), 79-91, 2020 | 12 | 2020 |
| Alcohol use cravings as a mediator between associated risk factors on increased alcohol use among youth adults in New York during the COVID-19 pandemic I Opara, S Malik, DT Lardier Jr, J Gamble-George, RJ Kelly, CN Okafor, ... Alcoholism treatment quarterly 39 (4), 415-429, 2021 | 11 | 2021 |
Andrew HolmesNIHVerified email at mail.nih.gov
